Market reserach

Digital health on the rise, new research shows

Digital technologies are proving to be benefiting healthcare according to the latest market research provided by the innovation consultancy Enspektos.

The research looks at the global digital health market, examining aspects such as investment, mobile technologies and global trends.

It highlights positive growth for the digital health market across all factors including infrastructure, regional diversity, health outcomes and financial strength. The research shows that mHealth is still the dominant area for advancements alongside big data, adherence and wearables.

More countries are investing in digital health technologies with governments in Australia and China making large investments in digital systems and artificial intelligence.

The research also shows that the healthcare industry is looking at ways to incorporate mobile, wearables, big data and other technologies to improve the diagnosis and management of diabetes, cancer, age-related conditions, asthma and depression.

Partnerships were identified as becoming a core strategy for pharmaceutical firms, hospitals and technology companies that are looking to build and commercialise digital solutions.

There has also been a rise in the number of social media posts, news headlines and articles focusing on digital and emerging technologies.

Other features of the research show that virtual reality in health in on the rise and is benefitting conditions such as anxiety, PTSD, depression and behavioural health conditions.

Fard Johnmar, founder and president of Enspektos, said: “Currently, thousands of organisations, start-ups, government agencies, universities and others are testing, developing and commercialising digital solutions globally. But, the full impact of these activities is not captured in quarterly investment numbers.”



'Digital health on the rise, new research shows' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

© 2017 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions